Androgen excess in women: experience with over 1000 consecutive patients.
about
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanInterventions for hirsutism (excluding laser and photoepilation therapy alone)Interventions for hirsutism excluding laser and photoepilation therapyInsulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndromePrevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteriaImpact of obesity on the risk for polycystic ovary syndromeScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase/17, 20-lyase activity in vivoEffects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeysHyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretionDiagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineEarly embryonic androgen exposure induces transgenerational epigenetic and metabolic changes.Association of ethnicity, Fitzpatrick skin type, and hirsutism: A retrospective cross-sectional study of women with polycystic ovarian syndromeAssociation of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.Rare extraperitoneal involvement with fatal outcome in a case of bilateral luteinized thecoma of the ovaries with sclerosing peritonitis.Effect of glucocorticoid-induced insulin resistance on follicle development and ovulation.Use of F 18-fluoro-D-glucose-positron emission tomography-computed tomography to localize a hilar cell tumor of the ovarySpecificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteriaNonclassic congenital adrenal hyperplasiaTumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic studyMutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome.PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis.Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.An interesting cause of hyperandrogenemic hirsutismVirilising ovarian tumour in a woman with an adrenal nodule.Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.Clinical, biochemical, and molecular characterization of macronodular adrenocortical hyperplasia of the zona reticularis: a new syndrome.Ovarian and adrenal androgens and their link to high human chorionic gonadotropin levels: a prospective controlled study.Epidemiology, diagnosis, and management of polycystic ovary syndromeIs hormonal treatment still an option in acne today?Endocrine check-up in adolescents and indications for referral: A guide for health care providers.The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence studyCommon variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome.Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control studyAcne in hirsute womenCardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome.Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours.Neuroendocrine causes of amenorrhea--an update.
P2860
Q21245262-C5B71DC5-B72E-423C-B265-FEE9AF026999Q24186393-B8C3737C-57ED-48D4-9D24-E6947D897223Q24201916-23842537-83BE-442F-9003-23F591D7C7A9Q24246323-2A6BA281-7C8F-4324-86AA-551F2A91C317Q24632310-E5139AC1-5670-4304-8490-B186419382E9Q24680958-370C1592-7B1F-48AD-A430-FE13625EE146Q28390200-845C198F-493E-4D93-A670-4B65F7812B5AQ28582335-DAF7F017-9DCF-4861-BA5B-753ED3AF0A76Q30389395-2FD63840-55A3-4F43-94A8-C513431D5E43Q30433601-3BCCE1DC-060B-4AFD-B72D-6C375AF35BA8Q33587845-86889D2C-4016-4B42-B64B-67047BED1F6CQ33631977-899C2563-61CA-463D-802E-490427F244FBQ33641723-1D0E24E3-3473-4DF7-817D-FF45306A6E5AQ33762034-E335E396-378C-4805-A853-037C1BAF3A53Q33796679-52403E4B-059C-4061-8D00-F2732FE0A7C9Q33806350-D497D619-6A10-43D8-8335-9BD18EC8D282Q33976837-6FC30BCE-B907-4A0C-84EF-AA4A33E08D68Q34009160-686B1F13-4C3C-4CCE-86DA-1D2CFC5306D8Q34021657-AD6E8B8B-659C-43A0-A15B-6D0F14CD5C3EQ34113904-CA4DA7B3-CB70-4EC7-9FC1-3723C7C6EDFBQ34148090-662BC363-15D1-4316-BE68-94A5711ED8ABQ34165728-71C9503A-F923-49EF-95B0-BE09D404DB3FQ34188287-7E19E385-5989-443D-AF21-C2DCF2E5604AQ34269555-F2DAE6B4-92FD-415D-AF03-D75185216652Q34312465-29E652DB-75D4-462D-8FD1-A3710814059CQ34457689-96217687-48F0-4B6C-B53B-CA56EF7B5BB9Q34530969-5A241EDC-38EC-42AC-8E24-7A1DF8F7E215Q34550556-FA922E6F-E9A0-41A5-AEE4-CC9F8397028EQ34622497-D56D9AF9-FA2D-45B3-84BC-9F9D91F8A02FQ34645796-565A7BEF-776C-4308-9B62-1D0894BB7A8EQ34658641-0D174413-B1AD-415A-A87B-C8447EDC9FD6Q34667697-F828F042-9C75-4DC5-AA6F-8A47787A462CQ34706476-7E288B2C-0C40-4367-A576-E00641D01CDFQ34761179-5B81E2C8-0A64-411B-B239-B31C8FA1863CQ34808919-4571C480-2EAD-4563-BCF7-B038A15EC898Q34872359-354CFDB9-B1CC-44ED-9C0D-7B989594EFC0Q34945922-93E591E8-562F-45B8-A636-D9D771319C80Q34979189-97FC33B8-A12A-4498-A4FC-56B3A5BBE7F6Q35015784-9AEA508E-F809-4DBC-9C7A-66EA5CB4F995Q35096850-A391DA85-9FCC-4EA7-8E8D-1798F661E9B2
P2860
Androgen excess in women: experience with over 1000 consecutive patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Androgen excess in women: experience with over 1000 consecutive patients.
@ast
Androgen excess in women: experience with over 1000 consecutive patients.
@en
type
label
Androgen excess in women: experience with over 1000 consecutive patients.
@ast
Androgen excess in women: experience with over 1000 consecutive patients.
@en
prefLabel
Androgen excess in women: experience with over 1000 consecutive patients.
@ast
Androgen excess in women: experience with over 1000 consecutive patients.
@en
P2093
P356
P1476
Androgen excess in women: experience with over 1000 consecutive patients.
@en
P2093
Knochenhauer ES
Sanchez LA
Stephens KC
P304
P356
10.1210/JC.2003-031122
P407
P577
2004-02-01T00:00:00Z